Lauren Merendino - Chief Commercial Officer at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
DAWN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Lauren Merendino - trading volume in the past year for Day One Biopharmaceuticals, Inc.

Holdings reported by Lauren Merendino for Day One Biopharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50.8K $453K $8.91 Nov 17, 2025 Direct
Stock Option (right to buy Common Stock) 90K Nov 6, 2025 Direct Common Stock
Restricted Stock Unit (RSU) 44.3K Nov 15, 2025 Direct Common Stock

Transactions reported by Lauren Merendino for Day One Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.